The physiological role of opioid peptides in the rat striatum was sought by intracellular recording in vitro. Excitatory synaptic potentials (mediated by glutamate or aspartate) and inhibitory synaptic potentials (mediated by GABA) were isolated pharmacologically and/or by positioning the stimulation electrode over the external capsule. Opioid agonists and antagonists selective for fi-, 6-, and K-receptors were applied by superfusion.
Two main actions of opioids were observed. First, F-and &selective opioids presynaptically inhibited the excitatory postsynaptic potential, whereas only a-selective opioids decreased the inhibitory synaptic potential. Second, a small subpopulation of cells (not medium spiny neurons) were hyperpolarized by L-selective agonists. The results indicate that the main action of opioids on striatal neurons is presynaptic inhibition of the corticostriate excitatory synaptic input.
The opioid peptides enkephalin and dynorphin are abundant within the rat neostriatum, and opioid receptors are expressed at relatively high levels. Enkephalin immunoreactivity is particularly marked in the AChE-poor patch compartment (Graybiel et al., 198 l) , and enkephalin coexists with GABA in a subset of medium spiny neurons, which provide a major output of the striatum to the globus pallidus (Cue110 and Paxinos, 1978; Graybiel and Ragsdale, 1983) . Dynorphin, on the other hand, is colocalized with GABA in the neurons that project to the substantia nigra (Anderson and Reiner, 1990) . The medium spiny neurons provide recurrent collaterals (Park et al., 1980) , suggesting that opioids might be involved in synaptic feedback within the striatum.
Receptors for both p-and b-selective opioids are found in the rat striatum. P-Receptors are concentrated in striatal patches, whereas b-receptors are more diffusely distributed through patch and matrix, particularly in the ventrolateral striatum (Herkenham and Pert, 198 1; Graybiel and Ragsdale, 1983; Mansour et al., 1987; see Graybiel, 1990) . It is known that morphine and @-endorphin can cause stereotypic behavior and even catalepsy in rats (see Blasig, 1978) , but there is little information available about opioid action at the cellular level. This lack of information is more striking in view of recent reports that enkephalin immunoreactivity is selectively reduced in the external pallidum of patients suffering from Huntington's disease (Albin et al., 1989) . Opiates inhibit the firing of neurons in the striatum of the anesthetized rat (Bradley and Gayton, 1976; Nicoll et al., 1977) , but with single unit recording in vivo one cannot distin-guish between direct actions on the cell that is recorded and actions due to changes in firing of other cells that are synaptically connected. The present experiments used intracellular recording in vitro so that presynaptic actions and direct postsynaptic actions of opioids could be differentiated.
Materials and Methods
Rats (male Sprague-Dawley) were anesthetized with halothane and killed by a heavy blow to the chest that broke major blood vessels. The brain was removed into cold (1-4"C) physiological saline, and a vibratome was used to cut slices (300 pm). The orientation of the slice was about 30" rostral-up from the horizontal plane. A slice was completely immersed in physiological saline in the recording chamber, secured between two nylon meshes. The physiological saline flowed at 3 ml/min and was preheated so as to be at 36°C as it passed over the tissue. Its composition was (in mM) NaCl, 126; KCl, 2.5; NaH,PO,, 1.2; MgCl,, 1.3; CaCl,, 2.4; glucose, 10; NaH,CO,, 26; saturated with 95% 0, and 5% CO,. Neurons were impaled with glass microelectrodes containing potassium chloride (2 M; resistance, 50-l 50 Mn). Membrane potential was recorded with an Axoclamp 2A preamplifier. Synaptic potentials were also recorded on a digital storage oscihoscope-(Tektronix 2230) and an X-Y recorder (Model 200. The Recorder Co.).
Synaptic potentials were evoked by electrical stimulation using a bipolar concentric electrode (Rhodes Medical Instruments). Synaptic potentials mediated by excitatory amino acids were evoked either by placing the stimulating electrode on the corpus callosum or external capsule or by focal stimulation with bicuculline (30 PM) or picrotoxin (100 PM) in the superfusing solution; in both cases, the synaptic potentials were completely blocked by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and DL-2-aminophosphonovaleric acid (APV) (see Jiang and North, 1991) . Synaptic potentials mediated only by GABA were isolated by focal stimulation, with CNQX and APV in the superfusing solution; the resulting synaptic potentials were completely blocked by bicuculline (30 PM) or by picrotoxin (100 PM) (Jiang and North, 1991) . Synaptic potentials were usually evoked at intervals of 10 set; potential amplitudes before and after adding drugs were measured by averaging responses to 8 or 16 stimuli.
Drugs were applied by changing the superfusing solution to one that differed only in its content of the drug. Opioid agonists used were [MeF]enkephalin (nonselective), DAGO (Tyr-o-Ala-Gly-MePhe-Gly-01; r-receptor selective), DPDPE (Tyr-o-Pen-Gly-Phe-D-Pen; a-receptor selective), and U50488.
benzeneacetamide methane sulfonate; K-receptor selective). Opioid antagonists used were naloxone (nonselective), CTAP (n-Phe-Cys-Tyr-r+Trp-Arg-Thr-Pen-Thr-NH*; p-receptor selective), and ICI174864 (N,N-bisallyl-Tyr-Aib-Aib-Phe-Leu-OH, Aib=amino-isobutyrate; d-receptor selective). Glutamate and GABA were applied either by superfusion (10 mM, 5-l 0 set only) or by ejecting a few nanoliters of a solution (10 mM) from the tip of pipette positioned in the solution above the surface of the slice; a pressure pulse of 70 kPa for 50 msec was typically used.
Results
The results are taken from intracellular recordings from 143 principal neurons and 9 secondary cells. Principal cells have very negative resting potentials (about -90 mV) and an inwardly rectifying potassium conductance; secondary cells are less polarized (about -60 mV) and have a hyperpolarization- activated cation conductance (I") (Uchimura et al., 1990; Jiang and North, 199 1) . There is evidence that the principal neurons are the main projection cells (presumably medium spiny neurons) whereas the secondary neurons are interneurons (Nisenbaum et al., 1988; Wilson et al., 1990; Jiang and North, 199 1) . Although both types of neuron receive synaptic inputs mediated by excitatory amino acids and by GABA (Jiang and North, 199 l) , the effects of opioids were studied only on synaptic potentials in principal cells.
Opiates reduce the synaptic potential mediated by excitatory amino acids [MeVlenkephalin reduced the amplitude of the synaptic potential in 68 of 92 cells tested (74%) (Fig. 1, Table 1 ). The reduction began within 1 min of changing the superfusing solution to one that contained enkephalin, and reversed within 3-6 min when the enkephalin was washed from the tissue. In about one-third of cells, the synaptic potential amplitude increase above its control value for l-3 min as the enkephalin was washed out. This action of enkephalin was seen in cells that were hyperpolarized, cells that were depolarized, and cells in which membrane potential was unaffected (see below), and there was no obvious correlation between this action and the change in resting potential.
The inhibition of the synaptic potential by enkephalin was related to the concentration applied and reached a maximum of about 40% (Fig. 2) . The inhibition of the synaptic potential was also seen with selective p-receptor agonist DAGO and with the &receptor-selective agonist DPDPE, Figures 1 and 2 show the inhibition caused by different concentrations of these agonists. When the synaptic potential was depressed by DAGO or DPDPE, it was also depressed by enkephalin. U50488H (30 PM) had no effect on the synaptic potential (n = 6).
In naloxone (lo-300 nM), the concentrations of [Mets]enkephalin had to be greatly increased to observe a similar inhibitory effect; the dissociation equilibrium constant of naloxone was estimated to be 20 and 36 nM in two cells in which two to four concentrations of enkephalin were applied first in the absence and then in the presence of naloxone (10, 30, and 300 nM).
Experiments with CL-and &selective antagonists sustained the conclusion that both p-and &receptors were involved in the presynaptic inhibition. ICI174864 (300 nM), a selective antagonist at &receptors (Cotton et al., 1984) significantly reduced the inhibition caused by [Met5]enkephalin and DPDPE but did not affect the inhibition caused by DAGO (Fig. 1B) . In eight cells, [Mets] enkephalin (30 PM) inhibited the synaptic potential by 3 1 * 4.0% in control conditions and by 20 f 2.9% in presence of ICI174864 (p < 0.05). Inhibition by DPDPE (1 PM) was by 36 f 4.8% in control and by 9.2 f 3.1% in ICI174864 (n = 6; p < 0.01). Inhibition by DAGO (1 FM) was by 25 f 5.1% in control and by 19 f 2.5% in ICI174864 (n = 6; p > 0.05). CTAP (300 nM), a selective antagonist at F-receptors (Kramer et al., 1989) completely abolished the inhibition by DAGO (1 PM) (n = 2). When a combination of CTAP and ICI 174864 was applied, the inhibition of the synaptic potential by enkephalin (30 PM) was also blocked completely (n = 3) (Fig. 1B) . A higher concentration (1 PM) of CTAP reduced the synaptic potential by lo-25% of the control. Glutamate microejection (10 mM, 70 kPa, 1 O-l 00 msec) produced a depolarization of 5-20 mV in amplitude and 5-10 set in duration. Enkephalin (10-100 PM) did not alter this depolarization whether (n = 3) or not (n = 5) TTX (1 PM) was present (see Fig. 4A ).
Opiates reduce the synaptic potential mediated by GABA [Mets] enkephalin (30 KM) reduced the synaptic potential by 30 f 7.8% in six cells (Fig. 3) and had no effect in four. DPDPE (1 PM) depressed the synaptic potential in all five cells tested (by 28 + 7.2%) ( Table 1) . DAGO (1 PM; n = 5) and U50488H (30 PM; II = 3) had no effect. ICI174864 (300 nM) completely abolished the inhibitory action of enkephalin (n = 5) and DPDPE (n = 3) (Fig. 3) but CTAP (300 nM) had no effect (n = 3).
Brief application of GABA by superfusion ( 10 mM, 5-l 0 set) depolarized cells by 8-25 mV for 20-60 sec. Enkephalin (lO-100 PM) did not alter this depolarization (n = 4) (Fig. 4B ).
Opioids hyperpolarize a subset of neurons
Most secondary cells were hyperpolarized by enkephalin (30 MM; 5 of 9 cells) ( Table 1) . Although the effect was small (2.6 + 0.68 mV), it was quite reproducible on a given cell and was sufficient to block completely the firing of action potentials (Fig.  5B) . Secondary cells were also hyperpolarized by DPDPE (0.3-1 PM; n = 3) but not by DAGO (1 PM; n = 6).
Eighteen percent of principal cells (n = 93) were hyperpolarized by 3.8 f 0.34 mV (n = 17) (Figs. 4A, 5B; Table 1 ); eight cells were depolarized by 2.1 f 0.22 mV ( Table 1 ). The hyperpolarization was accompanied by a small decrease in input resistance (14 + 1.1%; n = 17). The hyperpolarization usually became less when enkephalin was applied repeatedly to the same cell; it was not affected by TTX (1 PM; n = 3). DAGO (0.3 and 1 PM; n = 4) also hyperpolarized principal cells, but DPDPE (1 PM; n = 5) had no effect (Fig. 5A ). Hyperpolarizations were completely blocked by naloxone (1 PM; n = 6).
Discussion
Opiate actions on extrinsic synaptic inputs to the striatum Striatal neurons receive excitatory synaptic inputs from a number of sources. A predominate input is from all regions of the cerebral cortex (Glees, 1944; Gerfen, 1984; McGeorge and Faull, 1989) , and the transmitter is a glutamate-like excitatory amino acid (Spencer, 1976; Cordingley and Weight, 1986; Malenka and Kocsis, 1988) . The reduction by opioids of the synaptic potential is interpreted as an inhibition of release of excitatory amino acid from corticostriate fibers (hereafter referred to as row, The reduction was blocked by ICI174864 (0.3 PM). Resting potential was -90 mV. glutamate) because opioids did not reduce the depolarization caused by direct application of glutamate. Some other agonists (muscarine: &t&a et al., 199 1; baclofen: Seabrook et al., 1990; Uchimura and North, 1991; carbachol: Malenka and Kocsis, 1988; adenosine: Malenka and Kocsis, 1988; Uchimura and North, 1991) also inhibit the release of glutamate measured electrophysioiogically. However, the maximal inhibition of synaptic potential by opioids was only 40%, whereas the other agonists cause close to 100% inhibition. It is possible that all presynaptic fibers express opioid receptors but these couple only weakly to inhibition of glutamate release, although complete inhibition of release can be observed where opioids inhibit transmitter release from peripheral neurons (North and Williams, 1983) . Another possibility is that the synaptic potential results from glutamate release from two sets of presynaptic fibers that are both excited under the present experimental conditions; release from one set might be completely inhibited and release from the others unaffected.
Both cc-and s-receptors appear to be present on the glutamatecontaining fibers, although one cannot determine if they are on the same or different fibers on the basis of the present results. Autoradiographic studies show that r-receptors are most dense in patches of the striatum, whereas b-receptors are more uniformly distributed (Herkenham and Pert, 198 1; Mansour et al., 1987; Tempel and Z&in, 1987) . We do not know if any given cell in the present study was located in the patch or matrix; however, Kawaguchi et al. (1989) did not find any obvious electrophysiological differences between the cells in the two compartments.
Extracellular recording in vivo has shown that opioids inhibit the firing of striatal neurons; in those experiments the cells must be induced to fire by application of an excitatory amino acid ( Fry and Zieglginsberger, 1979; Hakan and Henriksen, 1989) . The depolarization of the applied excitatory amino acid would presumably sum with ongoing excitatory synaptic input to bring the cell to threshold; the presynaptic inhibition of that input observed in the present study could thus be responsible for the inhibition of firing seen in vivo. Opioid actions on GABA release within the striatum The GABA-mediated synaptic potential results from stimulation of local cells or terminals, most probably collaterals of the medium spiny neurons themselves (see Jiang and North, 199 1) . This was selectively reduced by activation of b-receptors. Inhibition of GABA release by opioids has also been shown by neurochemical measurements on slices of rat globus pallidus (Dewar et al., 1987) , where much of the GABA would be expected to be in terminals of striatal neurons; in those studies inhibition was observed with a nonselective agonist (DADLE, Tyr-D-Ala-Gly-Phe-D-Leu) but not with a p-selective agonist (FK33824, Tyr-D-Ala-Gly-MePhe-Met(O)-01) or ethylketazotine, a result consistent with involvement of &receptors. Inhibition of GABA-mediated synaptic potentials by opioids is seen in several other areas of the brain (see North, 199 1) . In the hippocampus (Nicoll et al., 1980) , the GABA-releasing terminals are provided by local interneurons; these neurons also express opioid receptors, activation of which results in membrane hyperpolarization (Madison and Nicoll, 1988) . In the case of the striatum, the GABA component of the synaptic potential arises largely from collateral branches of the medium spiny neurons themselves; this implies that the cell bodies might also express b-receptors. However, only a small proportion of the principal cells were hyperpolarized, and this involved CL-rather than &receptors.
Opioids inhibit voltage-dependent calcium currents in several tissues (see North, 199 l) , and this provides another mechanism by which &receptor activation might inhibit GABA release. Consistent with this, we found in preliminary studies that DPDPE (1 PM; 7 of 10 cells) and DAGO (1 PM; 3 of 8 cells) reduced the amnlitude and duration of the calcium action potential, recorded In TTX (1 PM), and barium (1 mM) or tetraethylammonium (20 mM).
sponses of two types of rat striatal neurones in vitro. J Physiol (Lond) 443:533-553.
Direct actions of opioids on striatal neurons About 50% of secondary cells were hyperpolarized by DPDPE but not by DAGO, suggesting that at least a subset of secondary cells express &receptors. Although conclusions regarding the secondary cells are suspect because of the small sample, the hyperpolarization was reproducible and sufficient to inhibit spontaneous firing (Fig. 5 ). This result is of interest in light of the proposal that these cells are striatal interneurons, which would include cholinergic neurons. Opioids inhibit the release of ACh from striatal tissue, and this is thought to involve the d-receptor (Mulder et al., 1984; but see Lapchak et al., 1989) .
This raises the possibility that some secondary cells expressing &receptors are the large choline@ aspiny cells. Intracellular recording from neurochemically identified cells will be needed to resolve this important question, but this will be difficult in view of the low abundance of the cholinergic neurons (see Wilson et al., 1990 ).
